Pharmacological re-evaluation of a GABA B receptor antagonist CGP 47332A in rat brain

By Ong J.   Marino V.   Parker D.A.S.   Kerr D.I.B.   Froestl W.  

European Journal of Pharmacology, Vol. 383, Iss. 2, 1999-10 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite

Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function

By Varga G.   Kordas K.   Burghardt B.   Gacsalyi I.   Szenasi G.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 315-323

Elsevier

Access to resources Recommend Favorite

Behavioral Changes Induced by GABA-Receptor Agonists in Lymnaea stagnalis L.

By Romanova E.V.   Rubakhin S.S.   S.-Rozsa K.  

General Pharmacology, Vol. 27, Iss. 6, 1996-09 ,pp. : 1067-1071

Elsevier

Access to resources Recommend Favorite

Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK B receptor antagonist, l-365,260, in rat brain

By Ge J.   Long S.K.   Kilpatrick I.C.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite

M100907, a selective 5-HT 2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

By Habara T.   Hamamura T.   Miki M.   Ohashi K.   Kuroda S.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 189-194

Elsevier

Access to resources Recommend Favorite